Patent · US Active

Treatment of metastatic tumors

US9603952B2 · kind B2 · utility

1Cited by
36References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2015
Grant dateMar 28, 2017
Priority date
Expiry dateMay 4, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to methods and methods for the treatment, inhibition and/or reduction, and detection of metastatic tumors. In some embodiments, the inventive methods include systemic (e.g., intravenous) administration of a chlorotoxin agent that may or may not be labeled. In some embodiments, the inventive methods allow treatment, inhibition and/or reduction, and detection of metastases in the brain. In some embodiments, neovascularization is inhibited and/or newly formed vessels are caused to regress.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.